‘Hold by his fingernails.’ The Massachusetts biotech industry is gearing up for another tough year. – The Boston Globe
Because of all this, startups hoping to go public haven’t dared set foot in a tumultuous and deflated stock market. Many businesses are simply trying to survive until there is an economic turnaround. Some have recently gone bankrupt, including Clovis Oncology, a once-promising Colorado cancer company, and Faze Medicines, a Cambridge neurological disease start-up. “There …
